Hostname: page-component-76d6cb85b7-xh428 Total loading time: 0 Render date: 2026-07-26T09:18:17.664Z Has data issue: false hasContentIssue false

Evolution of quality of life assessment in head and neck cancer

Published online by Cambridge University Press:  29 June 2007

Randall P. Morton*
Affiliation:
Department of Otolaryngology, Green Lane Hospital, Green Lane West, Auckland 3, New Zealand
*
Professor Randall Morton, Department of Otolaryngology, Green Lane Hospital, Green Lane West, Auckland 3, New Zealand.

Abstract

Quality of life assessment as part of clinical practice in head and neck oncology began over 40 years ago. Early studies were narrative and cross-sectional; these were followed, at first, by simple quantitative measures of various parameters and later by longitudinal studies of greatercomplexity. More recently quality of life has been employed in a randomized clinical trial of head and neck cancer.

Quality of life has evolved to become a standard means of assessing clinical outcomes, and an accepted end point measurement in clinical trials, to be considered alongside survivorship and side effects/complications.

Information

Type
Review-Article
Copyright
Copyright © JLO (1984) Limited 1995

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable